EGFR and breast cancer: Additionally, EGFR and HER2 interact with the nongenomic signalling pathways of ER; they regulate the expression of ERα isoforms and play major roles in the development of tamoxifen resistance in breast cancer by providing alternative pathways for cancer growth [18].